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There is growing evidence that micronutrient intake has a significant effect on the toxicity and
carcinogenesis caused by various chemicals. This paper examines the effect of micronutrient
status on the toxicity of four nonessential metals: cadmium, lead, mercury, and arsenic.
Unfortunately, few studies have directly examined the effect of dietary deficiency or
supplementation on metal toxicity. More commonly, the effect of dietary alteration must be
deduced from the results of mechanistic studies. We have chosen to separate the effect of
micronutrients on toxic metals into three classes: interaction between essential micronutrients
and toxic metals during uptake, binding, and excretion; influence of micronutrients on the
metabolism of toxic metals; and effect of micronutrients on secondary toxic effects of metals.
Based on data from mechanistic studies, the ability of micronutrients to modulate the toxicity of
metals is indisputable. Micronutrients interact with toxic metals at several points in the body:
absorption and excretion of toxic metals; transport of metals in the body; binding to target
proteins; metabolism and sequestration of toxic metals; and finally, in secondary mechanisms of
toxicity such as oxidative stress. Therefore, people eating a diet deficient in micronutrients will be
predisposed to toxicity from nonessential metals. Environ Health Perspect 106(Suppl 1):
203-216 (1998). http://ehpnetl.niehs.nih.gov/docs/1998/Suppl-1/203-216peraza/abstract.html
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Introduction
Research on the effects ofmicronutrients on
toxicity and carcinogenicity caused by vari-
ous chemicals has produced growing evi-
dence in the field of micronutrient intake
and reduction oftoxicity. We have reviewed
the literature on this topic; however, few
studies have directly examined the effect of
dietary deficiency or supplementation on
metal toxicity. More commonly, the effect
ofdietary alteration must be deduced from
the results ofmechanistic studies.
This paper examines the effects of
micronutrients on the toxicity ofcadmium,
lead, mercury, and arsenic - four nonessen-
tial metals. The effects ofmicronutrients on
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these metals are separated into three classes.
The first class deals with the interaction
between essential micronutrients and toxic
metals during uptake, binding, and excre-
tion. The second class deals with the influ-
ence ofmicronutrients on the metabolism of
these toxic metals. The third class describes
the effect of micronutrients on secondary
effects ofmetals.
Micronutrients can affect toxicity of
metals by interacting with the metal at its
primary site ofaction. Examples ofthis type
ofinteraction include the effects ofcalcium
on lead, phosphate on arsenate, and zinc on
cadmium. In these cases the toxic metal
exerts its effect by interfering with the
action of the essential compound. By this
argument, increasing the availability ofthe
essential micronutrients should decrease
the toxicity of toxic metals. More lead is
absorbed by people on a calcium-poor diet
than bythose on a calcium-rich diet.
Micronutrients can also modify the
body's response to toxic metals by altering
their metabolism and transport. Methionine
can prevent methylmercury central nervous
system (CNS) toxicitybyblocking transport
of the methylmercury-cysteine complex
into the brain via the large neutral amino
acid transporter. Zinc increases synthesis of
metallothionein (MT), a thiol-rich protein
that sequesters cadmium and prevents acute
hepatotoxicity, leading instead to chronic
kidney toxicity as cadmium-MT is excreted
from the liver and absorbed by the kidney.
Finally, there are a number of other
possible interactions ofmicronutrients with
secondary mechanisms of toxicity of non-
essential metals. An example of this is the
protective effect ofvitamin E on methylmer-
cury toxicity. Vitamin E is an antioxidant
and prevents free radical injury caused by
methylmercury.
Nutrition and Its Effects
on Cadmium Toxicity
Cadmium, a group IIB metal on the
periodic table, is a nonessential trace ele-
ment. It is present as a contaminant in
food (leafy vegetables, grains, and cereals),
water, and tobacco leaves, as well as being a
byproduct of zinc and lead mining and
smelting. Because of its widespread nature,
cadmium can either be ingested via contam-
inated foods or inhaled. Even in small
amounts (-200 ppm) significant damage
occurs to the kidneys and to the gastroin-
testinal tract in mammals (1). Other mani-
festations of cadmium toxicity include
mild anemia and osteoporosis. The most
pronounced effects occur in the kidney.
Only when significant cadmium damage
such as proteinuria and decreased renal
function has occurred does significant
cadmium excretion occur. Unfortunately,
there are few if any symptoms of chronic
exposure to small amounts of cadmium.
Therefore, by the time symptoms are appar-
ent, hypertension or coronary arterydisease
may exist in the cadmium-intoxicated
patient. Increased cadmium levels are asso-
ciated with coronary artery disease, hyper-
tension, emphysema, and other chronic
pulmonary diseases. This could be the
reason cigarette smokers are more prone to
acquiring hypertension, coronary artery
disease, and emphysema (2).
The most dangerous characteristic of
cadmium is that it accumulates throughout
a lifetime. Cadmium accumulates mostly
in the liver and kidney and has a long
biological half-life of 17 to 30 years in
humans. In fact, it has been claimed that
approximately one-third of the cadmium
accumulated in the body of an adult was
absorbed during the first few years oflife
(3). A possible explanation of this claim
could be the increased amount of milk
ingested during infancy. Research has
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shown that whole-body retention oforally
administered '09Cd in rats was about 15
times greater in milk-fed animals than in
those receiving normal diets from 3 to 52
weeks ofage (4). Because retention ofnono-
rally administered cadmium was not affected
by this diet, it is apparent that a diet con-
sisting entirely ofmilk influences cadmium
metabolism only at the intestinal level. The
high absorption in the young may result
from pinocytotic absorption of proteins
and other macromolecules (5). The effect
of the milk diet could be related to the
binding of cadmium to these proteins.
Therefore, the increased intestinal absorp-
tion ofcadmium in the presence of a milk
diet is probably attributable to the specific
transport ligands present in the milk.
As previously mentioned, cadmium is a
nonessential and toxic metal found through-
out the environment. Cadmium interacts
with the metabolism offour metals essential
to nutrition: zinc, iron, calcium, and copper
(1,6-10). Table 1 shows major cadmium
interactions with these micronutrients and
other dietary components. Another impor-
tant nutritional aspect of cadmium is its
interaction with the sulfhydryl-rich protein
MT (11,12). These and other factors are
important in determining the susceptibility
ofan individual to cadmium toxicity.
Cadmium-Zinc Interactions
Probably one ofthe most well recognized
and well studied metal-metal interactions in
the human body is that which occurs
between zinc and cadmium. There are many
similarities between the two metals. Both
cadmium and zinc are members of the
group IIB metals. Both metals have a similar
tendency to form tetrahedral complexes.
Therefore, it seems likely that the two met-
als would have similar interactions with the
human body. Evidence ofsupport for this
theorycomes from various sources. The sites
ofabsorption for cadmium occur mainly in
the duodenum and early jejunum, whereas
zinc is absorbed in the jejunum and ileum
(13). Cadmium has an inhibitory effect on
the activity ofzinc-containing enzymes such
as carboxypeptidase (14) and ax-mannosi-
dase (15). Indeed, cadmium replaces zinc in
MT (1). There are claims ofactivity reduc-
tions ofother zinc-containing enzymes that
could be pertinent to the toxicity associated
with cadmium. Cadmium reduces renal
leucine aminopeptidase activity in vivo, an
activity that might be responsible for the
development ofproteinuria (16).
The toxicity of cadmium may result
from disturbances in zinc metabolism,
Table 1. Major cadmium interactions with micronutrients and other dietary components.
Metal Toxicity
Cd Anemia; osteoporosis; proximal
tubular disfunction leading to
hypertension, coronary artery disease,
and chronic pulmonary diseases
Metal-nutrient Interaction and mechanism Effect of nutrient on metal toxicity
Cd-zinc Competes for GI absorption; Cd interferes Reverses Cd toxicity (i.e., decreases
with zinc metabolism growth, increases lesions and
testicular necrosis)
Cd-iron Cd decreases iron absorption and Supplementation corrects anemia:
metabolism (Cd possibly binds with increases hematocrit and increases
ferritin and transferrin) hemoglobin levels
Cd-calcium Cd decreases intestinal calcium transport; Sufficiency protects against bone
increases Cd deposits in bone tissue in a deformities, osteomalacia,
calcium-deficient state and osteoporosis (Itai-ltai disease)
Cd-copper Cd interferes with copper metabolism, Corrects Cd-induced decreased
possibly by decreasing copper absorption plasma ceruloplasmin concentrations
Cd-protein Low-protein diet results in increased Sufficiency prevents Cd-induced
Cd uptake decreased growth, decreases
MTsynthesis, and increases bone
deformities
Cd-selenium Selenium shifts Cd binding to MT can now bind essential nutrients
higher molecularweight proteins
GI, gastrointestinal.
leading to the description of cadmium as
an antimetabolite of zinc (17). If the diet
contains inadequate amounts ofzinc, toxi-
city from cadmium exposure can be induced
at much lower cadmium intake levels than
from a diet containing adequate zinc levels.
This can be attributed to the observation
that high levels ofdietary cadmium lead to
decreased absorption and tissue levels of
zinc. Furthermore, some of the symptoms
ofchronic cadmium toxicity are similar to
those ofzinc deficiency (18). For example,
growth failure (19), parakeratotic lesions
(20), and impaired glucose tolerance (21)
occur in both cases. Cadmium-induced tes-
ticular damage arises from competition
between cadmium and zinc for binding
sites on essential enzymes required for
gametogenesis (22). In rat studies, when
dietary zinc is low (5 ppm), pathologic
lesions in the liver, lung, heart, and testes
were found (23) even though the kidney
has been identified as the target organ for
cadmium accumulation (24). In fact, the
renal proximal convoluted tubules of
Sprague-Dawley rats fed a zinc-deficient
diet containing 100 ppm cadmium develop
degenerative changes such as cytoplasmic
vacuolation, mitochondrial swelling, and
coagulative necrosis (25).
Symptoms of cadmium toxicity can be
eliminated entirely by using a zinc supple-
ment. This finding further demonstrates
the antagonism between zinc and cad-
mium. The pathologic lesions caused by
cadmium found in the liver, lung, heart,
and testes ofzinc-deficient rats can be dis-
pelled when a 40-ppm zinc supplement is
administered. Cadmium toxicity has also
been reversed in chicks given zinc supple-
ments (26). Zinc supplements are impor-
tant during the last two trimesters of
pregnancy because a significant decrease in
plasma zinc levels has been observed in
nonoccupationally cadmium-exposed
women in southern Catalonia, Spain (27).
The testicular necrosis described previously
can be prevented by injection with zinc
prior to cadmium exposure. Also, the ratio
of zinc to cadmium concentrations is
important in determining whether an
industrial worker is susceptible to hyper-
tension and/or coronary artery disease
(28). The most compelling reason for the
protective effects of zinc against cadmium
toxicity is that zinc induces the production
of the metal-binding protein MT (29).
This cadmium-binding protein will be
discussed later.
Cadmium-Iron Interactions
One of the symptoms associated with
cadmium intoxication is the development of
anemia in the exposed individual, a result of
the inhibitory effect of cadmium on iron
metabolism and absorption. Cadmium
decreases hematocrit and hemoglobin levels
in exposed workers. Rats receiving a diet
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with 100 mg cadmium/kg for several weeks
have shown reduced liver and kidney
concentrations ofiron (29). This could be
attributable to the interference ofcadmium
with iron absorption at the intestinal level.
Cadmium binds to liver ferritin, which is
also present in the intestinal mucosa and
involved in the mucosal uptake and transfer
of iron. It has been suggested that higher
gastrointestinal absorption ofcadmium is
due to lower body iron stores as measured
bythe concentrations ofserum ferritin (30).
The protein transferrin, which donates iron
to the heme moiety in hemoglobin synthe-
sis, binds to a variety ofmetals in addition
to iron. Ferritin or transferrin could be
involved in the cadmium-iron interaction
observed duringcadmium intoxication.
In rats, iron supplementation corrects
the anemia caused by cadmium exposure
(31). This is not surprising because cad-
mium produces the same type of anemia
observed when the animal is iron deficient.
Iron supplementation also eliminates other
cadmium toxiceffects such as reducedgrowth
rate and lowered hemoglobin and hemat-
ocrit levels. An important result ofresearch
aimed at studying this iron-cadmium inter-
action showed that ascorbic acid protects
markedly against anemia and growth
depression produced in young Japanese
quail receiving 75 ppm cadmium in the
diet (32). Ascorbic acid does not have a
direct effect on cadmium, but the nutrient
improves iron absorption in the gastroin-
testinal tract. It has also been postulated
that in addition to this effect, ascorbic acid
plus iron might inhibit the intestinal
absorption ofcadmium (7).
Cadmiumn-Caldum Interactions
The interaction between cadmium and
calcium was hardly recognized until devel-
opment of the chronic cadmium syn-
drome, Itai-Itai disease, in Japan. This
disease was characterized in a population of
Japanese women by the development of
bone deformities, osteomalacia, and an
increased risk of contracting osteoporosis
(33). These unfortunate women have an
increased risk ofdeveloping Itai-Itai disease
because their normal diet, which consists
mostly ofrice and other grains, is deficient
in calcium. In rats, cadmium has an
inhibitory effect on intestinal calcium
transport that is stimulated by vitamin D
(34). The bone deformities have been
attributed to cadmium deposits in bone tis-
sue that interfere with calcification, decalci-
fication, and bone remodeling (35).
Another sign of cadmium toxicity with
regard to calcium is the hypercalciuria seen
in mostwomen with Itai-Itai. This increased
urinary excretion of calcium could be
attributable to a direct interaction of
cadmium with the calcium reabsorption
process or to the toxic actions ofcadmium
against the renal tubules in general. As has
been stressed for zinc and iron, an adequate
supply of calcium protects against symp-
toms ofcadmium toxicity. The microbial
enzyme phytase improves the apparent
absorption of calcium and magnesium in
albino rats while lowering liver and kidney
cadmium accumulation (36).
Cadmium-Copper Interactions
Dietary supplementation with copper can
reduce the mortality rate and severity of
anemia in experimental animals receiving
large amounts of cadmium in their diet.
Copper metabolism was seriously disturbed
in pregnant ewes receiving cadmium in
their diet. Both liver and plasma copper
concentrations were markedly reduced, as
evidenced bydeterioration ofthewool (37).
The most obvious disturbance in copper
metabolism caused by cadmium is the
reduced plasma ceruloplasmin concentra-
tions (37). Ceruloplasmin is the protein
responsible for transporting copper through-
out the circulatory system. This drop in
copper and ceruloplasmin levels is indica-
tive ofcopper deficiency and can be elimi-
nated by increasing dietary copper intake.
This work was important because the levels
ofcadmium fed to lambs simulated typical
conditions found in contaminated pastures
in the vicinity ofindustrial complexes. This
study emphasizes the link between envi-
ronmental exposure to heavy metals and
nutritional problems. Another explanation
for the cadmium-copper interaction is that
the two metals compete for binding sites
on MT (38). Copper displaces cadmium
from MT because of its higher affinity for
the protein (39). This is evident in the pork
industry in which pigs fed an excess ofcop-




Incorporation of cadmium in the
sulfhydryl (cysteine)-rich protein MT is
one of the principal detoxification mecha-
nisms against the metal. MT is specific not
only for binding cadmium but also for
binding copper, mercury, silver, and zinc.
In fact, MT synthesis is induced by the
presence of these metals as evidenced by
increases in MT mRNA (41). The main
physiologic role of MT is to act as a
homeostatic control mechanism by con-
trolling the metabolism ofboth copper and
zinc. Therefore, binding ofa nonessential
metal such as cadmium to MT is a fortu-
itous result of the chemical similarity
between cadmium and the essential trace
metals. Cadmium has a higher affinity for
MT and in fact displaces zinc from the cys-
teine binding sites but does not displace
copper because this essential trace metal
has higher MT affinity (39). The free
essential trace metals could then stimulate
the production ofmore MT or be excreted
in the urine, which would explain the defi-
ciencies in these two metals observed dur-
ing cadmium exposure. Zinc and copper
supplements are thought to act by induc-
ing MT synthesis, which allows the body
to be adequatelysupplied with enough MT
to combat the cadmium insult.
Even though MT offers mostly protec-
tive effects against cadmium toxicity, there is
evidence that it is indirectly involved in con-
tributing to cadmium's main toxic effect:
renal failure. In the urine ofcadmium-dosed
animals, a large amount ofcadmium-MT
complex was recovered, indicating that the
kidney is not very efficient at MT reabsorp-
tion (42). This complex is somewhat
retained by the kidney and the protein is
rapidly degraded, leaving free cadmium to
accumulate in the kidneys. Therefore, MT is
the vehicle that transports cadmium to its
toxic siteofaction, the kidney.
OtherCadmium-Nutrient
Interactions
A low-protein diet also makes one more
susceptible to cadmium toxicity. Feeding
experimental animals a low-protein diet
before cadmium administration results in
increased cadmium uptake by the whole
body, which leads to decreased growth and
increased bone deformities (43). Another
predisposing factor is that protein produc-
tion decreases; in other words synthesis of
MT, the primary cadmium detoxification
protein, occurs at a much lower rate.
Nutritional studies have shown that
selenium offers some protection against
acute cadmium-induced toxicity. The pro-
tective effects of selenium probably come
into play by the shifting ofcadmium bind-
ing from MT to higher molecular-weight
proteins (44). This allows MT to be
unencumbered and therefore able to bind
essential nutrients such as zinc and copper.
Studies also have been conducted on
the effect ofvitamins on cadmium toxicity.
Although the exact mechanism is unknown,
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vitamin C supplementation reduces
elevated cadmium levels in the kidneys and
livers ofpigs fed a copper-rich diet (40).
The addition ofmicrobial phytase counter-
acted the decrease in growth and zinc sta-
tus brought on byphyticacidandcadmium.
Phytase also lowered liver and kidney cad-
mium concentrations (45). A significant
attenuation of cadmium-induced tissue
injury was observed in retinol-pretreated
rats, possibly because ofa 7-fold increase in
MT production in the liver and less cad-
mium accumulation in the lung, kidney,
and testis (46).
Nutrition and Its Effects
on Lead Toxicity
Lead causes many adverse health affects,
including toxicity of the nervous, hema-
topoietic, renal, endocrine, and skeletal
systems, with the CNS as the primary tar-
get organ. Presently, impairment ofcogni-
tive and behavioral development in infants
and young children is the toxic effect of
greatest concern.
Toxicity, which is both age and lead
dose dependent, occurs from low-level expo-
sures from various environmental sources
including air, food, and water. However,
removal ofleaded gasoline in the United
States and other countries and elimination
of lead-soldered cans in the canning of
food products greatly reduced the extent of
exposure from these sources. Lead-contain-
ing paint, used in older homes built before
the 1970s or in urban, lower-income hous-
ing, is a major source oflead exposure for
young children. These children may sus-
tain many of the risk factors such as low
socioeconomic status and calcium and iron
insufficiencies known to intensify the man-
ifestations oflead exposure. Lead toxicity,
including its effects on the CNS, is known
to occurwith blood concentrations between
0.48 and 0.72 pmol/liter, and over 1 mil-
lion children in the United States have
blood concentrations in this range orhigher
(47,48). In the adult subpopulation, physi-
ologic conditions associated with bone
resorption, including pregnancy, lactation,
and aging, can also potentiate the CNS
effects oflead and enhance exposure.
Calcium supplements, wine, leaded
crystal glass, and lead-containing glazed
pottery are additional sources oflead expo-
sure (49,50). Imported ceramics from
Mexico, China, Korea, Italy, and Spain can
release large amounts oflead into food and
drink (51). Contamination from this
pottery is now a leading public health
problem in Mexico (52). Numerous
studies have shown that the lead content of
glazed ceramics used to prepare and store
food is a major predictor ofblood leadlevels
in Mexico, especially in children (53,54).
Lead-Calcium Interactions
Extensive clinical and experimental evidence
supports the significance oflead-calcium
interactions (55). These interactions occur
at the cellular and molecular levels and are
a result of the ability oflead to mimic or
displace calcium during specific physio-
logic processes. Studies show that lead
inhibits the release ofneurotransmitters by
blocking the entry of calcium into nerve
terminals (56,57), by competing with
calcium for uptake by calcium channels
(58,59), and by inhibiting all subtypes of
calcium channels (60-62). It is likely that
lead blocks calcium efflux from cells by
substituting for calcium in Ca2+/Na+
adenosine triphosphate (ATP) pumps.
This mechanism ofinterference could pos-
sibly explain how lead interacts with cal-
cium in the intestine (63,64). Another
critical interaction between lead and cal-
cium occurs within cells, where lead inter-
feres with calcium binding to receptors
coupled with second messenger functions
(65-67). This mechanism involves a com-
petition between lead and calcium for
calcium receptor proteins like calmodulin
and protein kinase C (PKC). Lead acts by
displacing the calcium bound to calmod-
ulin and affecting the free concentration of
calcium inside the nerve terminal, which
leads to the stimulation of neurotransmit-
ter release (67-69). Lead appears to have a
better capacity to activate PKC, thus caus-
ing an increase in its activity. This can lead
to increases in cell division and proliferation
and increases in cellular responses to PKC
such as cell-cell communications,
cytoskeletal organization, and the release
of neurotransmitters (67,69-71). Recent
evidence also shows that lead alters inosi-
tol polyphosphate receptor binding in the
rat brain, possibly resulting in altered
intracellular calcium levels that may influ-
ence neuronal activity (72). Evidence for
all these interactions suggests that lead-
induced disruption ofcalcium homeostasis
in the immature and developing brain may
interfere with normal development (73).
CalciumEffects
onLeadAbsorption
Gastrointestinal lead absorption and
retention constitutes the major pathway
of lead intake (74) and depends on the
micronutrient status ofthe gastrointestinal
lumen. Adults absorb approximately 10%
ofingested lead and small children absorb
approximately 50% ofingested lead. This
difference may be the result of a higher
density of intestinal transport proteins
duringperiods ofhigh growth (75).
Absorbed lead enters the blood and
reaches the bones and soft tissues of the
body, including the liver, from which it is
gradually excreted (76). Long-term studies
indicate that lead is not excreted at the
same rate as it is absorbed (77,78). Lead,
which is excreted both in urine and feces,
continuously accumulates in the body
tissues with age.
Nutritional factors are thought to playan
important role in lead poisoning. Enhanced
susceptibility to lead intoxication in cases of
dietary calcium deficiency has been attrib-
uted to increased intestinal absorption (79)
and body lead retention (80). Calcium and
lead compete for similar binding sites
on intestinal mucosal proteins, which are
important in the absorptive process (81).
These shared binding sites on absorptive
proteinswould explainwhysufficientdietary
calcium decreases lead absorption. A study
by Six and Goyer (80) has shown that rats
fed a low-calcium diet containing varying
amounts oflead had higher blood and tissue
concentrations oflead than rats fed a nor-
mal-calcium diet. This study demonstrates
that dietary calcium deficiency increases lead
concentration in critical organs.
Other studies have also shown that
absorption oflead by the gastrointestinal
tract is inversely related to dietary calcium.
A study of pregnant women in Mexico
City (82) found that use of lead-glazed
ceramics was associated with elevated
blood lead levels and that consumption of
tortillas (rich in calcium) lowered blood
lead levels in women of lower socioeco-
nomic status. This decrease was not signifi-
cant, but consumption of milk products
significantly decreased blood lead levels in
women ofhigher socioeconomic status.
Studies on the effect ofa dietary excess
of calcium on lead toxicity (83-85) indi-
cate that a small decrease in lead absorp-
tion and blood concentration can be
achieved; however, this effect is not as dra-
matic as the effect ofcalcium insufficiency
on lead uptake and retention. Therefore
the achievement ofadequate rather than
excessive dietary calcium seems to be more
useful in combatinglead intoxication.
IeadandBoneMetabolism
More than 95% ofthe adult body burden
oflead is in the bone (86). Therefore bone
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metabolism plays as important a role as do
absorption and excretion in the ultimate
fate oflead in the human body (87).
Reviews on the influences ofcalcium,
phosphorous, and vitamin D on the uptake
oflead bybone are extensive (75,86,88,89).
A study ofpostpartum women in Mexico
City (90) determined that use oflead-glazed
ceramic ware along with lower consump-
tion of high calcium-containing foods
contributed significantly to higher bone
retention oflead. Studies in rats also show
that a phosphorous-deficient diet increases
lead retention and that calcium- and phos-
phorous-deficient diets have an additive
effect on lead retention (91). Thus, evidence
suggests that dietary calcium and phospho-
rous sufficiencies can have an additive
inhibitory effect on the absorption and
retention oflead (92,93).
Vitamin D not only increases intestinal
calcium and phosphate absorption but also
stimulates the coabsorption ofother essen-
tial minerals like magnesium, iron, and
zinc and the absorption of toxic metals
such as lead (88,94-96). One effect ofvit-
amin D that may be involved in increased
intestinal absorption oflead is the induc-
tion of calcium-binding proteins by
intestinal cells (97). Studies show that lead-
binding properties of these calcium-bind-
ing proteins could indeed result in vitamin
D enhancement of lead absorption and
deposition in both the kidney and bone
(98). Furthermore, when calcium levels are
low, serum levels ofthevitamin D hormone,
1,25-dihydroxy-vitamin D, are elevated to
stimulate intestinal absorption of calcium
and synthesis ofcalbindin-D, a calcium-
binding protein (99). Thus, this provides
another mechanism by which lead absorp-
tion could increase in times of calcium
deficiency (79,97).
Following deposition in the bone, lead
can be mobilized in response to both
physiologic and pathologic conditions.
Mobilization oflong-term stores of lead
from the maternal skeleton may be a major
determinant in transfer oflead from mother
to infant during pregnancy and lactation.
Studies in rats indicate that lead stored in
bone as a result ofprevious maternal expo-
sure should be considered a major source of
selfintoxication and milk contamination in
lactating mothers (100). Astudy in Sweden
found a decrease in serum calcium levels
and an increase in blood lead concentra-
tions in pregnant women, possibly because
of mobilization oflead from bone (101).
After onset of menopause there can be a
marked mobilization ofcalcium from bone
and hormone replacement therapy may
reduce the return ofendogenous lead to the
circulation (102).
Lead-IronInteractions
Nutritional iron deficiency and iron
deficiency during periods ofrapid growth,
such as infancy, in laboratory animals also
enhances lead absorption and promotes lead
toxicity. This is more evidence for concern
that pregnant women and young children
may be more susceptible to dietary lead
(103). However, unlike calcium deficiency,
iron deficiency in rodents does not appear
to result in redistribution oflead to non-
bone tissues (104); it only affects the gas-
trointestinal absorption of lead (105). A
negative relationship between dietary iron
intake and blood lead levels was also found
in a study ofpreschool children (106). Iron
deficiency is recognized worldwide as one of
the most prevalent nutritional problems;
impairment of cognitive function among
iron-deficient children has also been recog-
nized (107,108). However, the mechanism
by which iron deficiency is associated with
behavioral alterations is not dear.
The effects oflead and iron on the heme
biosynthetic pathways have been extensively
investigated and characterized. Lead inhibits
two major enzymes of the heme biosyn-
thetic pathway: delta-aminolevulinic acid
dehydratase (&-ALAD) and ferrochelatase.
Furthermore, lead seems to raise delta-
aminolevulinic acid (&-ALA) synthase activ-
ity, which leads to an accumulation of
6-ALA (109,110). Lead interferes with
mitochondrial energy metabolism, which is
necessary to reduce ferric iron to ferrous
iron before insertion ofiron into the por-
phyrin ring. When iron deficiency is pre-
sent, ferrochelatase is more sensitive to these
effects oflead (110) and results in depres-
sion ofhematopoiesis. Therefore, iron sup-
plementation may prevent this toxic effect
oflead on hematopoiesis.
Additional studies demonstrate the
capacity of MT to attenuate the lead-
induced inhibition of 6-ALAD (111). A
recent study by Church et al. (112) sug-
gests the existence ofa MT-like protein in
erythrocytes that binds lead and possibly
protects against lead toxicity by rendering
that lead unavailable for retention in
target organs.
OtherLead-NutrientInteractons
Several other dietary components affect the
absorption oflead; these factors, alongwith
calcium, iron, and vitamin D, may hold
some promise in decreasing the severity of
lead toxicity, especially in children. The
major interactions between lead and these
micronutrients as well as other dietary
components are summarized in
Miller et al. (113) presents an extensive
review of interactions between lead and
essential elements, but additional and more
recent studies have been conducted. Regular
meals as well as higher total food and fat
intake have been associated with decreased
gastrointestinal lead absorption (114-117/.
Zinc influences both tissue accumulation
oflead and susceptibility to lead toxicity,
particularly the inhibitory effects oflead on
6-ALAD (103,118,119). Studies show that
as dietary zinc increases, lead absorption
and its subsequent toxicity decrease, indi-
cating that zinc exerts its effect on lead in
the gastrointestinal tract. In addition, Flora
et al. (120) determined that simultaneous
administration of zinc and of the lead
chelator, calcium disodium EDTA, results
in potentiated chelation oflead. Recently
the effect ofselenium on lead-induced neu-
rotoxicity was studied in rats. Selenium
was shown to have a possible protective
effect on lead inhibition ofsuccinic dehy-
drogenase, acetylcholine esterase, and the
sodium/potassium ATPase in the rat brain
(121). Another study (122) demonstrated
that selenium supplementation during
chelation oflead in rats may be a useful
adjunct in chelation treatment of lead
intoxication caused by the activation of
lead-inhibited 6-ALAD byselenium.
Experimental, epidemiologic, and
clinical investigations have repeatedly
shown that nutritional intervention can
play an important role in the toxicity asso-
ciated with lead, especially in more vulner-
able populations. When lead exposures are
overwhelming, nutritional factors probably
do not prevent lead intoxication. However,
low-level exposures to lead are ofgreatest
concern in children, who experience more
severe developmental effects than other
subpopulations. Therefore, the importance
ofnutrition as a component ofa preventa-
tive strategy is much greater for children
and other susceptible subpopulations.
Nutrition and Its Effects
on MercuryToxicity
Mercury is one ofthe most common heavy
metals present in our environment. It has
been used for more than 3000 years in
medicine and in industry. It has been used
therapeutically as a cathartic, diuretic, anti-
inflammatory, antiparasitic, vermifugan,
and in dental amalgams as well as folk
remedies. Although most ofits medical uses
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Table . Major lead interactions with micronutrients and other dietarycomponents.
Metal
Pb
Metal-nutrient Interaction and mechanism
Pb-calcium Competes forbinding sites on
intestinal mucosal proteins
Pb-phosphorous Mechanism unclear; phosphorous may








Vitamin D increases intestinal absorption
ofcalcium, phosphate, and Pbvia
induction of intestinal binding proteins
Competes for iron transport systems
(i.e.,ferritin) ofthe intestine
Involves complex mechanisms that are
notyet clear
Competes for GI uptake, perhaps on the
same MT-like transport protein
Selenium activates Pb-inhibited 8-ALAD
have been discontinued, industrial uses of
mercury such as in gold mining, paint, and
batterymanufacture are increasing (123).
Mercury exists in the environment as
elemental mercury (Hg0), organic mercury
(i.e., CH3HgX), and inorganic salts (i.e.,
Hg2+). Hg0 is used in thermometers,
switches, and barometers. Hg0 is poorly
absorbed from the gastrointestinal tract
but is almost completely absorbed through
the respiratory tract, rapidly crossing the
blood-brain barrier and causing neurotoxic-
ity. Its vapor accounts formost occupational
mercury exposures. At the cellular level the
dissolved vapor is oxidized to Hg2+, which
causes nephrotoxicity. Hg2+ can be found in
preservatives, dyes, and disinfectants. This
form ofmercury is hydrophilic and thus is
the most nephrotoxic form, affecting mainly
the straight segment ofthe proximal tubule.
Hg0 causes neurotoxic effects by increasing
permeability ofthe plasma membrane to
calcium (124). The mechanism oftoxicity
of inorganic mercury is by impairing
mitochondrial function. Mercury possibly
promotes mitochondrial membrane leak-
age and increases mitochondrial oxygen
Toxicity
Impairment ofcognitive functions
(especially inchildren); CNS symptoms
include irritability, confusion, lethargy,
coma, andconvulsions; hematopoiesis
depression
Effect of nutrient on metaltoxicity
Sufficiency decreases GI absorption
ofPb and decreases concentration of
Pb in critical organs
Sufficiency decreases bone retention
ofPb; in combination with calcium
sufficiency, can have an additive
inhibitory effect on Pbabsorption
and retention
Enhances Pb absorption and deposition
inkidneyand bone, promoting Pbtoxicity
Supplementation may decrease Pb
absorption and toxicity(i.e., hematopoiesis
depression); does not affect redistribution
of Pb to nonbone tissues
Greater intake andfrequency of meals
are associated with decreased Pb GI
absorption, leading to decreased Pb
toxicity
Supplementation decreases Pb GI
absorption, decreases Pb tissue
accumulation, and thus decreases Pb
toxicity (i.e. inhibitory effects on 8-ALAD)
Useful as an adjunct in chelation
treatment ofPb intoxication
consumption with subsequent increased
production ofhydrogen peroxide (124).
Methylmercury is the form most frequently
involved in mercury food poisoning.
Methylmercury, a byproduct ofthe chemi-
cal industry, is produced by methylation of
inorganic mercury in aquatic sediments
and soils (125). This is the form that
affects fish in contaminated lakes or rivers.
It is lipophilic and readily absorbed by
inhalation, dermal contact, and ingestion
(diet) and distributes within a few days to
all tissues in the body. It crosses the
blood-brain and placental barriers to reach
its principal target tissue: the brain. The
mechanism oftoxicity ofmethylmercury is
not yet known. Recent studies have sug-
gested that cleavage of methylmercury
gives rise to the generation ofoxygen radi-
cals, ultimately leading to lipid peroxida-
tion and neuronal cell damage (126). The
results ofmethylmercury neurotoxicity are
damaged microtubule structures in injured
cells; inhibition ofastrocyte uptake ofsero-
tonin, aspartate, and glutamate; suppres-
sion of N-type and L-type calcium
channels in PC12 cells; and suppression of
they-amino-n-butyric acid receptor-channel
complex activity in rat dorsal ganglion neu-
rons (126). The biological half-life of
methylmercury in human tissues is about 50
days, with elimination via conversion to
inorganic mercury and its excretion in the
urine(125).
Exposure to many heavy metals occurs
through food primarily in two ways:
ingesting metal-contaminated food (i.e.,
fish) and storing and cooking food in pot-
tery painted with metal-containing paints.
Exposure to mercury via foodstuffs has
been studied infish, duck eggs, and canned
tuna as well as several different market bas-
kets (the diet ofpeople from a specific area
or region) have been tested for mercury
content around the world (127-135).
Mercury levels have been determined
mainly in fish and in fish-eating people of
many countries induding Canada and the
United States. Shubat et al. (128) sug-
gested that fishing and fish-preparation
customs influence the potential for mer-
cury exposure. These influential factors
include the site offishing (contaminated
areas) and the fish tissues eaten. Cultural
backgrounds (among immigrants, for
example) influence the potential for mer-
cury exposure first because ofeating cus-
toms (may eat the whole fish with almost
no waste) and second because ofthe lan-
guage barrier, which may interfere with the
understanding ofrules about fishing and
fish eating. Shubat et al. (128) found these
problems with Laotian immigrants and
refugees who settled in metropolitan areas
ofMinnesota. Mercury levels increase with
the age and size ofmost species and tissues
ofmarine organisms (133). Eating fish can
also lead to indirect mercury exposure of
children. Boischio and Henshel (127)
reported that the placenta and mother's
milk are important routes ofmercury expo-
sure in infants. Other foods have also been
examined for mercury content and been
found safe. A study in Taiwan byJeng and
Yang (136) found that duck eggs, which
are commonly included in the diet, were
safe from mercury contamination. Similarly,
Yess (137) found that canned tuna had
mercury below the U.S. Food and Drug
Administration action level. Different mar-
ket baskets have also been examined for
total mercury (136-142). Most of the
studies reported mercury levels below the
provisional tolerable weekly intake or the
acceptable dailyintakeproposedbythe Food
andAgricultural Organization ofthe United
Nations (Rome, Italy) and theWorld Health
Organization (5.0 pg/kg/day). However,
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Chan et al. (140) found that the wildlife of
the Canadian Arctic, which constitutes the
traditional diet ofindigenous people, is an
important source of mercury exposure.
Mercury levels in most ofthe animals exceed
the average weekly intake ofmercury.
Foodstuffs can also become contami-
nated during the preparation process. The
use ofornamental ceramics (glazed pottery)
to store and cook meals in many develop-
ing countries (i.e., Mexico) (143) is known
to increase the risk ofheavy metal expo-
sure. Food can also become contaminated
with heavy metals during its handling and
storage with different kinds ofpapers and
board materials. Castle et al. (144) studied
different papers and board materials
intended for food contact and chemicals
with a potential to migrate to foods. In this
study, mercury was not detected above the
limits ofdetermination of0.4 mg/kg.
Mercury-elenium Interacdons
Selenium was discovered in 1817 by Jon
Jakob Berzelius (145). It is a nonmetal
with some metallic characteristics and it
occurs in nature as selenides oflead, cop-
per, mercury, and silver. Selenium is a
required dietary element for health, but it
is also a toxic material. Required selenium
levels for good health are between 0.04 and
0.1 ppm (145). In general, levels ofsele-
nium of5 to 10 mg/kg offood are consid-
ered toxic (146). The naturally occurring
levels ofselenium in foods are capable of
modifying methylmercury toxicity (147).
The first study reporting that selenium
counteracted acute mercuric chloride toxic-
ity was published in 1969 (148). At that
time selenium was reported to be highly
effective in treating chronic methylmercury
toxicity (149). The concentration ofsele-
nium used (5 ppm) was below the recom-
mended concentration ofdietary selenium
in contrast to the concentration of sele-
nium needed to protect against inorganic
mercury (around 40 ppm), which is above
the nutritional range.
Selenium's mechanisms ofprotection
against methylmercury and inorganic mer-
cury may be different. Selenium protection
against inorganic mercury may involve a
variety of mechanisms such as the direct
stoichiometric complexing ofmercury to
reduce its availability (150). The reduction
ofmercury availability has not been proven
because mercury levels are not decreased by
selenium. It may be possible that selenium
interferes with the metabolism ofinorganic
mercury by reacting with the mercuric ion
to form a compound that is less toxic than
the mercuric ion. Experiments on mice
indicate that the reaction between selenium
and mercury ions depends on the presence
ofreactive selenium (151). Selenium influ-
ences the oxidation rate ofHgo to mercuric
ions that seems to be species dependent
(146). The protection ofselenium against
methylmercury is not clear. Methylmercury
is degraded to mercuric ion. The rate of
this process is also species dependent.
Selenium may protect against methylmer-
cury as described for inorganic mercury.
There may also be another protective
mechanism involving selenium. When
methylmercury is degraded to inorganic
mercury, the methyl moiety can also be
further degraded by homolysis to methyl
free radicals (148). These molecules may
initiate a chain reaction peroxidation of
various lipid constituents. These products
result as part ofthe metal toxicity. Selenium-
dependent glutathione (GSH) peroxidase
protects the cells by catalyzing the reduc-
tion of hydrogen peroxide and other
organic hydroperoxides to products of
greater stability (152).
Mercury-VitaminEInteracdons
Vitamin E was first reported to protect
against methylmercury toxicity in 1974
and it was shown that high levels ofvita-
min E decreased mortality in Japanese
quail fed 30 ppm methylmercury (153).
The mechanism ofaction ofvitamin E is
that ofa scavenger of radicals that other-
wise initiate methylmercury breakdown.
Vitamin E also can react with methyl radi-
cals that might be formed in the break-
down. Other antioxidants may then be
expected to protect against not only mer-
cury but also other metal-induced toxici-
ties. However, the most effective action of
vitamin E may be related to its location in
the cell membranes (a result ofits physico-
chemical properties) and to its ability to
stabilize membranes by interacting with
unsaturated fatty acid chains (148).
OtherMercuryInteracdons
Hydrogen peroxide contributes to the
cytotoxicity ofmercuric chloride in vivoand
in vitro. The nonenzymatic scavenger for
hydrogen peroxide, pyruvate, and the enzy-
matic scavenger, catalase, reduce mercury-
induced cell injury (124). Methylmercury
neurotoxicity is blocked by other oxygen
radical scavengers such as GSH, catalase,
and cysteine (126). Methionine also affects
mercury toxicity (154). Methionine sup-
plementation depresses methylmercury-
induced weight loss and liver weight,
depresses deposition of mercury, and
prevents depression ofblood GSH peroxi-
dase in rats (154). Mercury also interacts
with the metal-binding protein MT, a low-
molecular-weight cytosolic protein. MTs
and MT-like proteins protect the biologic
system by binding metal ions. The in vitro
affinity ofmetals for MT is the following:
Zn <Cd < Cu <Hg (39). The presence of
Zn and Cu as essential metals and Cd as a
nonessential metal may affect mercury tox-
icity. MT-I and MT-II are present in most
if not all cells of the body and are readily
inducible both in vivo and in vitro (155).
MT-III is present only in the brain, pri-
marily in neurons, and seemingly is not
inducible (155). A summary ofinteractions
with micronutrients and other dietary
components can be found inTable 3.
Responses toMercuryToxicity
One ofthe toxic effects ofmercury is oxida-
tivelike toxicity. The exposure oftissues to
oxidative stress often instigates an antioxi-
dant response that defends against or limits
the severity ofthe oxidative injury. The
activity ofthe hydrogen-peroxide degrading
enzyme, GSH peroxidase, is decreased after
exposure to mercury, which may contribute
to increased renal generation ofhydrogen
peroxide. Another enzyme, heme oxygenase,
is markedly induced by mercury in the kid-
ney at early time points and may indicate a
protective response (124). As a possible
antioxidant response, the members ofthe bcl
genes, bc12and bcl, are induced bymercury
in the kidney (124). These genes protect
against apoptotic cell death. The bc2gene is
efficacious against oxidant-induced cell dam-
age and prevents cell death induced by GSH
depletion and the resulting oxidative stress
and lipid peroxidation (124). The bclx gene
is induced 16 hr after mercury treatment in
conjunction with bc12 and also protects
against oxidant-induced cell death. The cel-
lular site ofexpression ofthese two genes
(bcI2 mainly, bclx exclusively) is the cell
mitochondria, which is significantly altered
by mercury (124). The induction ofthese
two genes may represent a cytoprotective
response that may be particularly salutary to
the mitochondrion.
Nutrition and Its Effects
on Arsenic Toxicity
Arsenic is a naturally occurring element.
Most exposure is through consumption of
food and water. Although the mechanism
of chronic arsenic toxicity is not known,
studies ofpopulations in Taiwan (156),
Chile (157,158), and Mexico (159) living
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Table 3. Major mercury interactions with micronutrients and other dietary components.
Metal Toxicity
Hg Nephrotoxicity (impairment of
mitochondrial function ofthe
straight segment of proximal tubule
by inorganic Hg); neurotoxicity
(Hg0 increases permeability
of plasma membrane tocalcium)
Metal-nutrient Interaction and mechanism Effectof nutrient on metal toxicity
Hg-selenium
Inorganic Hg-selenium Complexing of Hg by selenium Reduces Hg availability, leading
to the formation of a less toxic
mercuric compound
Organic Hg-selenium Mechanism notclear; selenium may Protects the cell against Hg-induced
catalyze the reduction of H202 cell injury(oxidative stress)
and organic hydroperoxides
to products of greater stability
Hg-vitamin E Vitamin E reacts with methyl radicals Inactivates radicals
that might be formed in methylmercury
breakdown
Vitamin E interacts with unsaturated Stabilizes cell membranes
fattyacid chains in cell membranes
Vitamin E acts as a scavenger of radicals Decreases the presence of radicals
Hg-amino acids
Hg-cysteine Cysteine acts as a scavengerfor oxygen Reduces Hg-induced cell injury
radicals that might be formed during
methylmercury breakdown
Hg-methionine Unclear Prevents depression of blood
GSH peroxidase (rats);
prevents deposition of Hg
in areas ofendemically high arsenic (0.3 to
0.8 mg/liter drinking water) have shown
at least one ofthe following toxic signs:
hyperpigmentation, keratosis, skin cancer,
or Blackfoot disease, a vascular disease that
leads to gangrene in the extremities. Other
populations exposed to similar arsenic lev-
els in the United States did not exhibit
these health effects (160-162). This has
led to the suggestion that other factors may
play roles in the expression of chronic
arsenic toxicity, including differences in
duration ofexposure, form ofarsenic, and
nutritional status.
Cellular studies have shown that the
extent and type of damage caused by
arsenic depend on the form or species of
arsenic. Although the pentavalent inor-
ganic arsenate [As(V)] is most prevalent in
the environment, it is considered less toxic
than the trivalent inorganic arsenite
[As(III)]. As(V), however, can be reduced
to As(III) in the body. Although arsenate
can substitute for phosphate, thereby inter-
fering with ATP synthesis and energy pro-
duction (163), arsenite interacts with
thiols and affects many functional proteins
(164). As reviewed by Thompson (165),
inorganic arsenic in the body is methylated
by methyltransferase using S-adenosyl-
methionine as the methyl donor. The
methylated forms monomethylarsonic acid
(MMA) and dimethylarsenic acid (DMA)
are less toxic, have lower affinities for tissue
constituents, and are excreted in the urine,
thus making methylation a detoxification
reaction. Ingestion ofarsenic already in an
organic form, such as arsenobetaine (a
common contaminant in marine fish from
the bioaccumulation ofmicrobiologically
unchanged into the urine (166). The order
of toxicity of arsenic species in mammals
appears to beAs(III), As(V), MMA, DMA,
then other organic arsenic.
Direct studies on the effects ofnutrition
on arsenic toxicity have been hindered by
lackofan adequate animal model ofchronic
arsenic toxicity and carcinogenicity.
Populations exhibiting arsenic toxicity have
mainly been of low economic status and
suffering from some form ofmalnutrition.
Nutritional studies in Chile revealed food
energy and total protein intakes below
recommended daily allowances (167).
Concerns about low-protein diets prompted
a nutritional study by Engel and Receveur
(168), which showed that the exposed
population in Taiwan had protein and
methionine intakes that met recommended
levels. Questions have arisen aboutwhether
their cysteine and methionine levels
(while adequate for normal populations)
are below the methylation capacity needed
to detoxify the extra arsenic burden (169).
Mushak and Crocetti (170) have argued
that theoretically these micronutrient levels
still are adequate. The role of selenium
deficiencies in arsenic-induced skin cancer
has also been discussed (171). A compara-
tive studybyValentine et al. (172) initially
examined differences in selenium intakes
between populations in rural northern
Mexico and Edison, California, that were
exposed to similar levels of arsenic in
drinking water but exhibited different
extents oftoxicity. The study revealed that
the only difference nutritionally from the
recommended daily allowances was a
greater lack ofvitamin A in the Mexican
study group. These human studies along
with an understanding ofhow different
forms of arsenic exert their toxicities, are
metabolized and detoxified, and how else
arsenic may affect the body, provide
insight into how nutritional status may
ameliorate or aggravate arsenic toxicity.
Table 4 summarizes the major interactions




Arsenic in the form ofarsenate is chemically
similar to phosphate. It uncouples oxidative
phosphorylation by substituting for phos-
phate in ATP synthesis (163,173). That
phosphate and arsenate can share the same
transport mechanism is indicated by the
decrease in intestinal absorption ofarsenic
with phosphate infusion in the rat (174).
Theoretically, dietary phosphate could out-
compete arsenate uptake and decrease toxic-
ity. Whereas phosphate loading has been
used by some athletes to enhance perfor-
mance (175), the use ofthis supplement to
ameliorate arsenate toxicity has not been
studied. Phosphorus is so abundant in nat-
ural foods that phosphorus deficiencyalmost
neveroccurs naturally.
The chemical similarity between arsenic
and selenium, an essential micronutrient,
generally allows for antagonistic effects
between these two metalloids (176); how-
ever, there seems to be synergistic toxicity
between arsenic and methylated selenium
species (177). Unlike with phosphate,
there is no interaction between arsenic and
selenium gastrointestinal absorption (178).
Instead, selenium and arsenic each increase
the biliary excretion of the other (179).
Arsenic appears to abolish the anticarcino-
genic effects of selenium (180) but can
actually be therapeutic in alleviating
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Table 4. Majorarsenic interactions with micronutrients and otherdietary components.
Metal Toxicity
As Hyperpigmentation; keratosis; skin
cancer; vascular disease
Metal-nutrient Interaction and mechanism Effect of nutrient on metal toxicity
As-selenium Antagonistic effects Decreasesteratogenic toxicity
As-cysteine Sulfur-amino acid content affects GSH GSH detoxifies As
As-methionine levels; As binds thiol groups
As-protein
As-methionine Precursors of S-adenosyl methionine, Important forAs detoxification
As-choline which is used in methylation ofAs
As-protein
As-zinc Mechanism unknown Zinc pretreatmentassociated with
increased As elimination
As-vitamin E Antioxidants scavenge oxygen radicals Decreases damage to macro-
As-vitamin A formed during As metabolism molecules and decreases chance
of developing lung cancer
As-garlic extracts As binds to sulfur moieties ofgarlic Leads to alternative As
compounds binding and decreases
chromosomal aberrations
inorganic selenium toxicity (181). Selenium
can also alleviate arsenic toxicity. Selenate
partially prevents the uncoupling ofoxida-
tive phosphorylation by arsenate (182).
Selenium also decreases the teratogenic
toxicity ofarsenate in hamsters when both
salts are injected simultaneously (183).
Therefore, adequate or even extra selenium
in the diet may alleviate arsenic toxicity,
whereas a selenium deficiency may aggra-
vate arsenic toxicity. Aselenium deficiency,
however, does not explain the differences
in arsenic toxicity between populations in
Mexico and California, which were both
exposed to similar arsenic levels in drinking
water and had adequate selenium levels in
their diets (172). Hair samples show
decreases in selenium and iron levels
through the progression ofBlackfoot dis-
ease (184), perhaps implying a role for
these nutrients after all.
Arsenite interacts with thiol-containing
amino acids, peptides, and proteins (185). It
exerts its cellular toxicity by binding to key
sulfhydryl groups, which results in enzyme
inhibition. GSH is a thiol peptide and
antioxidant that plays an important role in
many xenobiotic detoxification reactions
including arsenic detoxification. Cellular
toxicity is inversely related to intracellular
GSH levels and is exacerbated by GSH
depletion. GSH levels can be affected to a
certain extent by nutritional status (186).
Low sulfur amino acid content ofthe diet
(i.e., cysteine or methionine) or more gener-
ally, low-protein diets, yield low GSH levels




A low-protein diet can aggravate toxicity in
another way. Low dietary intake ofmethio-
nine, choline, or proteins decreased arsenic
excretion (especially urinary excretion of
DMA) and increased the tissue retention of
arsenic in rabbits (188). Diets deficient in
methionine and choline decrease S-adenosyl-
methionine levels, therefore inhibiting
methyltransferase reactions (189), i.e.,
arsenic detoxification reactions.
Arsenic can induce increases in MT
levels (190), which implies that arsenic can
be detoxified by this low-molecular-weight,
cysteine-rich, metal-binding protein. Zinc-
induced increases in MT, however, do not
seem to be responsible for the protection
against arsenic lethality in mice pretreated
with zinc (191). Although the mechanism
for this tolerance to arsenic toxicity is not
known, zinc pretreatment was associated
with increased elimination ofarsenic.
Effects ofDiet onSecondary
ArsenicToxicEffects
During arsenic metabolism oxygen radicals
may be produced, possibly leading to
damage of DNA, proteins, lipids, and
other molecules. There is a positive correla-
tion between lipid peroxidation and arsenic
tissue concentrations in the livers, kidneys,
and hearts of arsenite-treated rats (192).
Arsenite induces the body's antioxidant
activities in human fibroblasts (193).
Arsenite induces heme oxygenase, leading to
heme degradation, iron release, and decreases
in the cytochrome P450 biotransformation
enzymes important in both endogenous
and xenobiotic metabolism (194).
Superoxide dismutase activity was also
increased by sodium arsenite treatment in
human fibroblasts (193). Dietary antioxi-
dants such as vitamins E and A may also
alleviate arsenic toxicity. Addition ofvita-
min E could at least in part prevent the
arsenite-induced killing of human fibro-
blasts (195). As mentioned previously a
role for vitamin A deficiency in the expres-
sion of arsenic toxicity has been implied
by the nutrition survey comparison
between populations in Mexico and
California (172). Dietary intake of fruits
and vegetables, particularly yellow and
light green vegetables (foods high in vita-
min A precursors), was inversely associated
with the odds ratio of lung cancer in tin
miners exposed to arsenic and other risk
factors (196).
Because ofarsenic's affinity for protein
sulfhydryls, many side effects can occur
from enzyme inhibition. Chronic arsenite
toxicity results in mitochondrial changes
that block lipoic acid-dependent dehydroge-
nase, which in turn inhibits glycolysis and
results in a demand for glucose and subse-
quently in hypoglycemia (197). Arsenicals
also inhibit pyruvate dehydrogenase in glu-
coneogenesis (198). Carbohydrate depletion
caused by gluconeogenesis depletion may
therefore aggravate arsenic poisoning.
Studies showstarved rats were more sensitive
to As(III) than rats with free access to food
(198), although starvation would also affect
other potentially important dietary factors.
Inhibition ofcitric acid cycle enzymes and
associated reactions in the P cells of mice
appears to induce features ofdiabetes (199).
It has been suggested that arsenic exposure
may play a role in the development ofdia-
betes mellitus because there is an association
ofthe disease with arsenic in drinking water
in Taiwan (200) and with arsenic from
occupational exposure in copper smelter
employees in Sweden (201).
Dietary supplements may also affect
arsenic toxicity andcarcinogenicity. Arsenite-
induced bone marrow chromosomal aber-
rations were decreased in mice fed crude
garlic extracts (202). This may be because
ofarsenite's affinity for the sulfur moieties
in many ofthe chemical compounds found
in garlic extract.
The effects of arsenic toxicity by other
heavy metals or contaminants found in the
diet are outside the scope ofthis discussion,
but it is evident that nutritional status may
play an important role in the expression of
arsenic toxicity. The most important factor,
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at least theoretically, is adequate protein
intake for the detoxifying methylation
reactions. Comparison studies have shown
that antioxidants such as vitamin A may
also be important in alleviating toxicity.
Because studies of these highly exposed
populations from developing countries are
the basis for setting regulatory levels in
other countries, the role ofnutritional sta-
tus on the effects of arsenic cannot be
overlooked. More research is needed to
determine which dietary factors may allevi-
ate or exacerbate arsenic toxicity. Whether
remediation ofdietary deficiencies will be
enough to handle the arsenic burden or
whether nutrient levels above the recom-
mended daily allowances will be necessary
remains to be determined.
Conclusions
There have not been many studies
designed specifically to address the effect of
micronutrient status on toxicity from
exposure to nonessential metals. Based on
data from mechanistic studies, the ability
ofmicronutrients to modulate the toxicity
of metals is indisputable. Micronutrients
interact with toxic metals at several points
in the body: absorption and excretion of
toxic metals; transport of metals in the
body; binding to target proteins; metabo-
lism and sequestration oftoxic metals; and
finally, in secondary mechanisms oftoxic-
ity (such as oxidative stress). Therefore,
people eating a diet deficient in micronu-
trients will be predisposed to toxicity from
nonessential metals.
The fact that dietary sufficiency can
have a significant impact on toxicity of
nonessential metals may greatly affect risk
assessment for these metals. Epidemiologic
studies used to set acceptable exposure lev-
els for nonessential metals in the United
States have been performed in other coun-
tries. The diets of individuals in these
countries are far different from diets in
the United States. Depending on the
micronutrient content ofthe diet, toxicity
may be significantly different in other
countries than in the United States. An
example is the development ofItai-Itai dis-
ease in calcium-deficient Japanese individ-
uals exposed to cadmium. Studies that
determine the impact of diet on toxicity
will make risk assessment more accurate.
The possibilities provided by the
interaction ofdietwith toxic metals are clear.
We can no longer afford to ignore the effect
ofmicronutrients on the health ofhumans
and animals exposed to toxic metals. The
typical remedy for toxic metal exposure has
been to remove the exposure source.
However, situations such as the arsenicism in
India today will arise-situations in which
millions ofpeople are affected and it is
impossible to remove everyone from expo-
sure. In these cases dietary manipulation
may provide the best defense and must be
understood to be ofuse.
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